Processing-deficient Progeroid Syndrome
📧 Sign up to get email alerts when something new happens for Processing-deficient Progeroid Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-03-21FDA Approved: ZOKINVY — Supplemental Application (Sentynl Therapeutics, Inc.)
FDA approved a supplemental application for ZOKINVY (lonafarnib) from Sentynl Therapeutics, Inc. under NDA 213969. The action approves chang…